By 2025, 80% of end-stage kidney disease patients are expected to receive home dialysis or kidney transplants
88% of patients receive treatment at dialysis centers
Understanding the cause of intradialytic hypotension or hypertension events
Determine what medication to prescribe in order to keep blood pressure stable during and after the treatment.
NICaS is designed to assist physicians to determine the patient’s body composition and the cause of intradialytic hypertension. Furthermore, hypotension is based on patients’ objective hemodynamic parameters. These parameters provide physicians with a deeper” understanding of the total dynamics that affect each patient’s individual hemodynamic status.
With NICaS, physicians can also be more effective in determining the proper dry weight and the dialysis session plan.
Accurate dry weight – no guessing
Significant decrease of intradialytic hypotension/hypertension events